RIA
RMD icon

RPG Investment Advisory’s ResMed RMD Stock Holding History

RPG Investment Advisory’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-48,831
Closed -$5.08M – 287
2019
Q1 		$5.08M Buy
48,831
+727
+2% +$75K 1.19% 45
2018
Q4 		$5.48M Buy
48,104
+338
+0.7% +$36.2K 1.37% 26
2018
Q3 		$5.51M Buy
+47,766
New +$5.23M 1.16% 37

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RPG Investment Advisory's RMD Position: Q2 2019 in Review

RPG Investment Advisory sold out of ResMed (RMD) in Q2 2019, closing a stake of 48,831 shares — an estimated $5.08M sold.

RPG Investment Advisory first reported a position in RMD in Q3 2018 and held it in 3 quarters. The position peaked at $5.51M in Q3 2018. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2019.

  • RPG Investment Advisory reported no remaining ResMed position as of Q2 2019 after selling out during the quarter.
  • RPG Investment Advisory sold 48,831 ResMed shares in Q2 2019, an estimated $5.08M.
  • RPG Investment Advisory first reported a position in ResMed in Q3 2018 and held it in 3 quarters.
  • RPG Investment Advisory's ResMed position peaked at $5.51M in Q3 2018.
  • 485 funds tracked by Wall St. Rank held ResMed as of Q2 2019.

Based on RPG Investment Advisory's 13F filing for Q2 2019, filed 10 Jul 2019.